Shares of Diploma PLC (LON:DPLM – Get Free Report) have been assigned a consensus rating of “Moderate Buy” from the eight ratings firms that are presently covering the firm, Marketbeat.com reports. Three equities research analysts have rated the stock with a hold recommendation and five have given a buy recommendation to the company. The average 12 month price objective among brokers that have covered the stock in the last year is GBX 6,788.75.
Several research analysts have recently commented on the company. Stifel Nicolaus boosted their target price on Diploma from GBX 6,200 to GBX 6,800 and gave the company a “buy” rating in a research note on Thursday, March 19th. JPMorgan Chase & Co. raised their price target on Diploma from GBX 5,120 to GBX 5,760 and gave the stock a “neutral” rating in a research report on Friday, March 27th. Jefferies Financial Group reaffirmed a “hold” rating and issued a GBX 7,000 price target on shares of Diploma in a research note on Friday, May 29th. Shore Capital Group reiterated a “hold” rating on shares of Diploma in a research report on Wednesday, March 18th. Finally, Berenberg Bank increased their price objective on Diploma from GBX 7,500 to GBX 9,000 and gave the company a “buy” rating in a research note on Tuesday, May 19th.
Get Our Latest Stock Analysis on DPLM
Diploma Trading Up 0.7%
Diploma (LON:DPLM – Get Free Report) last issued its earnings results on Tuesday, May 19th. The company reported GBX 74.70 EPS for the quarter. Diploma had a net margin of 9.42% and a return on equity of 18.55%. The company had revenue of £851.10 million for the quarter. On average, sell-side analysts anticipate that Diploma will post 163.7995512 earnings per share for the current year.
Insiders Place Their Bets
In other news, insider Katie Bickerstaffe purchased 177 shares of the company’s stock in a transaction on Wednesday, May 20th. The stock was acquired at an average price of GBX 6,730 per share, with a total value of £11,912.10. 1.14% of the stock is owned by insiders.
Diploma Company Profile
Diploma PLC, together with its subsidiaries, supplies specialized technical products and services in the United Kingdom, Continental Europe, North America, and internationally. It operates through three business sectors: Life Sciences, Seals, and Controls. The Life Sciences sector supplies technology-enabled products used in surgical procedures in operating theatres and endoscopy; testing equipment and services for clinical laboratories; and bio-pharma, food safety and testing, and other research-oriented products.
Featured Articles
- Five stocks we like better than Diploma
- 3 Rare-Earth ETFs That Help Investors Balance Exposure and Risk
- Microsoft Bets on In-House AI to Cut OpenAI and Anthropic Costs
- Delta Air Lines Lives Up to Its Claims: Shares Can Keep Climbing
- This Dividend ETF Choice Could Shape Your Income Strategy Through 2026
Receive News & Ratings for Diploma Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Diploma and related companies with MarketBeat.com's FREE daily email newsletter.
